RxDoctor Payments Data

Anola Tanga, MD

Psychiatry · Ogdensburg, NYNPI 1336151331

Payments from drug & device makers

$908in general payments, 2019–2025

Across 44 payments — averaging $20.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$292
  • Johnson & Johnson$171
  • Otsuka America Pharmaceutical, Inc.$123
  • AbbVie$76
  • E.r. Squibb & Sons, L.L.C.$64
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$49
  • plus $134 from 4 others

What the payments were for

  • Food & beverage$88197%
  • Education$273%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$908 in reported general payments places this provider in the 75th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York

Medicare billing

Part B allowed, 2024
$16,370
Medicare patients
50
Services billed
186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate52$177,125
Abilify MaintenaAripiprazole22$61,676
RexultiBrexpiprazole25$37,434
Risperdal ConstaRisperidone Microspheres26$33,038
VivitrolNaltrexone Microspheres15$25,610
LybalviOlanzapine/Samidorphan Malate13$22,075
VraylarCariprazine Hcl26$16,385
Aripiprazole110$11,961
Paliperidone ErPaliperidone25$11,134
AuvelityDextromethorphan Hbr/Bupropion16$6,638
DepakoteDivalproex Sodium13$5,570
Quetiapine Fumarate145$2,599
Divalproex Sodium ErDivalproex Sodium75$1,541
Mirtazapine87$1,345
Prazosin Hcl77$1,089

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$171$210,16378 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$123$99,11047 claims
Alkermes, Inc.Vivitrol, Lybalvi$33$47,68528 claims
AbbVieVraylar$76$16,38526 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,713 psychiatry providers in New York.

Other psychiatry in Ogdensburg

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →